Jean‐Luc Prétet
Biographic Data
| ID | 7766854 |
|---|---|
| NAME | Jean‐Luc Prétet |
| GIVEN NAMES | Jean‐Luc |
| FAMILY NAME | Prétet |
| SIGNATURE | PRÉTET J L |
| AFFILIATIONS | Centre Hospitalier Universitaire de Besançon |
| ORCID | 0000-0002-8430-214X |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 0 |
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
The nonavalent HPV vaccine showed significant increased potential impact compared to the HPV 6/11/16/18 quadrivalent vaccine for ICC, CIN2/3 and LSIL. Considering a 100% vaccine efficacy and high vaccine coverage, about 90% of ICC, CIN2/3, GW or anal cancer cases could be prevented by a nonavalent HPV vaccine in France
No prominent works on this page.
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
The nonavalent HPV vaccine showed significant increased potential impact compared to the HPV 6/11/16/18 quadrivalent vaccine for ICC, CIN2/3 and LSIL. Considering a 100% vaccine efficacy and high vaccine coverage, about 90% of ICC, CIN2/3, GW or anal cancer cases could be prevented by a nonavalent HPV vaccine in France
Anal cancer (1 work) · Cancer (1 work) · Cervical cancer (1 work) · Cervical Cancer and HPV Research (1 work) · Colorectal and Anal Carcinomas (1 work) · Epidemiology (1 work) · Genital warts (1 work) · Genotype (1 work) · Gynecology (1 work) · Head and Neck Cancer Studies (1 work)